Trial
NCT01898806
Intralesional Steroids in the Treatment of Alopecia Areata
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
University of Minnesota
Condition
Alopecia Areata
Intervention
Intralesional Triamcinolone 2.5 mg/ml
Why stopped
The PI left the Columbia University Medical Center. Study was not Completed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-06